TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs8062326
log Bayes Factor = 10.0922
Chromosome 16   position 19,156,016  (GRCh37) Explore rs8062326 on Ensembl!
Variant rs8062326 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Chapter IX Diseases of the circulatory system
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
I30-I52 Other forms of heart disease
1.000 0.000 0.000
Chapter X Diseases of the respiratory system
0.999 0.001 0.000
I51 Complications and ill-defined descriptions of heart disease
0.997 0.003 0.000
I10-I15 Hypertensive diseases
0.996 0.004 0.000
I47 Paroxysmal tachycardia
0.996 0.004 0.000
I12 Hypertensive renal disease
0.996 0.004 0.000
I12.0 Hypertensive renal disease with renal failure
0.992 0.008 0.000
Chapter XIV Diseases of the genitourinary system
0.989 0.011 0.000
I47.1 Supraventricular tachycardia
0.984 0.016 0.000
J09-J18 Influenza and pneumonia
0.982 0.018 0.000
N40-N51 Diseases of male genital organs
0.980 0.020 0.000
J20-J22 Other acute lower respiratory infections
0.978 0.022 0.000
N42 Other disorders of prostate
0.974 0.026 0.000
I51.8 Other ill-defined heart diseases
0.970 0.030 0.000
Chapter XX External causes of morbidity and mortality
0.968 0.032 0.000
N43 Hydrocele and spermatocele
0.963 0.037 0.000
J30-J39 Other diseases of upper respiratory tract
0.961 0.039 0.000
N25-N29 Other disorders of kidney and ureter
0.959 0.041 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.957 0.043 0.000
J18 Pneumonia, organism unspecified
0.954 0.046 0.000
Chapter V Mental and behavioural disorders
0.953 0.047 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.953 0.047 0.000
J22 Unspecified acute lower respiratory infection
0.953 0.047 0.000
I60-I69 Cerebrovascular diseases
0.951 0.049 0.000
Chapter VI Diseases of the nervous system
0.951 0.049 0.000
N43.3 Hydrocele, unspecified
0.950 0.050 0.000
I12.9 Hypertensive renal disease without renal failure
0.944 0.056 0.000
J18.1 Lobar pneumonia, unspecified
0.942 0.058 0.000
Chapter I Certain infectious and parasitic diseases
0.942 0.058 0.000
I31 Other diseases of pericardium
0.935 0.065 0.000
N28 Other disorders of kidney and ureter, not elsewhere classified
0.931 0.069 0.000
N17-N19 Renal failure
0.928 0.072 0.000
N42.8 Other specified disorders of prostate
0.924 0.076 0.000
I51.7 Cardiomegaly
0.923 0.077 0.000
G20-G26 Extrapyramidal and movement disorders
0.922 0.078 0.000
J32 Chronic sinusitis
0.922 0.078 0.000
I64 Stroke, not specified as haemorrhage or infarction
0.920 0.080 0.000
Chapter XV Pregnancy, childbirth and the puerperium
0.918 0.082 0.000
F40-F48 Neurotic, stress-related and somatoform disorders
0.916 0.084 0.000
I50 Heart failure
0.915 0.085 0.000
I20-I25 Ischaemic heart diseases
0.914 0.086 0.000
I05-I09 Chronic rheumatic heart diseases
0.904 0.096 0.000
G20 Parkinson's disease
0.896 0.104 0.000
Q60-Q64 Congenital malformations of the urinary system
0.894 0.106 0.000
I34 Nonrheumatic mitral valve disorders
0.893 0.107 0.000
N28.8 Other specified disorders of kidney and ureter
0.893 0.107 0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems
0.890 0.110 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.888 0.112 0.000
F41 Other anxiety disorders
0.888 0.112 0.000
J32.9 Chronic sinusitis, unspecified
0.884 0.116 0.000
F41.9 Anxiety disorder, unspecified
0.881 0.119 0.000
I31.3 Pericardial effusion (noninflammatory)
0.872 0.128 0.000
A30-A49 Other bacterial diseases
0.872 0.128 0.000
Y52 Agents primarily affecting the cardiovascular system
0.870 0.130 0.000
I47.2 Ventricular tachycardia
0.868 0.132 0.000
N18 Chronic renal failure
0.863 0.137 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.859 0.141 0.000
I50.1 Left ventricular failure
0.857 0.143 0.000
N42.9 Disorder of prostate, unspecified
0.856 0.144 0.000
N42.1 Congestion and haemorrhage of prostate
0.855 0.145 0.000
N42.0 Calculus of prostate
0.847 0.153 0.000
W20-W49 Exposure to inanimate mechanical forces
0.846 0.154 0.000
I60 Subarachnoid haemorrhage
0.842 0.158 0.000
I25 Chronic ischaemic heart disease
0.833 0.167 0.000
I51.6 Cardiovascular disease, unspecified
0.832 0.168 0.000
J39 Other diseases of upper respiratory tract
0.831 0.169 0.000
Q61 Cystic kidney disease
0.827 0.173 0.000
N41 Inflammatory diseases of prostate
0.823 0.177 0.000
G90-G99 Other disorders of the nervous system
0.821 0.178 0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified
0.821 0.179 0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.820 0.180 0.000
O34 Maternal care for known or suspected abnormality of pelvic organs
0.819 0.181 0.000
J00-J06 Acute upper respiratory infections
0.818 0.182 0.000
N17 Acute renal failure
0.815 0.185 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.814 0.186 0.000
J15 Bacterial pneumonia, not elsewhere classified
0.812 0.188 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.807 0.193 0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions
0.805 0.195 0.000
I47.0 Reentry ventricular arrhythmia
0.799 0.201 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.798 0.202 0.000
J95-J99 Other diseases of the respiratory system
0.796 0.204 0.000
I51.9 Heart disease, unspecified
0.792 0.208 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.790 0.210 0.000
I22 Subsequent myocardial infarction
0.789 0.211 0.000
J21 Acute bronchiolitis
0.789 0.211 0.000
I07 Rheumatic tricuspid valve diseases
0.787 0.213 0.000
Chapter VII Diseases of the eye and adnexa
0.787 0.213 0.000
I34.0 Mitral (valve) insufficiency
0.784 0.216 0.000
O42 Premature rupture of membranes
0.784 0.216 0.000
I25.2 Old myocardial infarction
0.781 0.219 0.000
B35-B49 Mycoses
0.775 0.225 0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue
0.773 0.227 0.000
I47.9 Paroxysmal tachycardia, unspecified
0.772 0.228 0.000
I11 Hypertensive heart disease
0.772 0.228 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.771 0.229 0.000
I30 Acute pericarditis
0.768 0.232 0.000
Q00-Q07 Congenital malformations of the nervous system
0.767 0.233 0.000
J38.3 Other diseases of vocal cords
0.764 0.235 0.000
N28.1 Cyst of kidney, acquired
0.764 0.236 0.000
J14 Pneumonia due to Haemophilus influenzae
0.763 0.237 0.000
J33 Nasal polyp
0.761 0.239 0.000
I51.0 Cardiac septal defect, acquired
0.760 0.240 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.760 0.240 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.759 0.241 0.000
J17 Pneumonia in diseases classified elsewhere
0.758 0.242 0.000
B90-B94 Sequelae of infectious and parasitic diseases
0.754 0.246 0.000
I33 Acute and subacute endocarditis
0.753 0.247 0.000
I25.8 Other forms of chronic ischaemic heart disease
0.753 0.247 0.000
I24 Other acute ischaemic heart diseases
0.752 0.248 0.000
A49 Bacterial infection of unspecified site
0.749 0.251 0.000
N30-N39 Other diseases of urinary system
0.749 0.251 0.000
O47 False labour
0.749 0.251 0.000
N26 Unspecified contracted kidney
0.747 0.253 0.000
O48 Prolonged pregnancy
0.747 0.253 0.000
W44 Foreign body entering into or through eye or natural orifice
0.747 0.253 0.000
O34.2 Maternal care due to uterine scar from previous surgery
0.747 0.253 0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.746 0.254 0.000
I51.4 Myocarditis, unspecified
0.744 0.255 0.000
O94-O99 Other obstetric conditions, not elsewhere classified
0.742 0.258 0.000
Chapter XXII Codes for special purposes
0.740 0.259 0.000
I31.9 Disease of pericardium, unspecified
0.740 0.260 0.000
N18.0 End-stage renal disease
0.740 0.260 0.000
J35 Chronic diseases of tonsils and adenoids
0.738 0.262 0.000
H53-H54 Visual disturbances and blindness
0.738 0.262 0.000
F40 Phobic anxiety disorders
0.737 0.263 0.000
N28.0 Ischaemia and infarction of kidney
0.736 0.264 0.000
Q80-Q89 Other congenital malformations
0.736 0.264 0.000
I46 Cardiac arrest
0.735 0.265 0.000
N17.9 Acute renal failure, unspecified
0.735 0.265 0.000
D70 Agranulocytosis
0.734 0.266 0.000
G80 Infantile cerebral palsy
0.734 0.266 0.000
I60.8 Other subarachnoid haemorrhage
0.734 0.266 0.000
J32.2 Chronic ethmoidal sinusitis
0.734 0.266 0.000
G83 Other paralytic syndromes
0.733 0.267 0.000
Chapter XXI Factors influencing health status and contact with health services
0.733 0.267 0.000
Q61.2 Polycystic kidney, adult type
0.733 0.267 0.000
Q61.3 Polycystic kidney, unspecified
0.732 0.268 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.732 0.268 0.000
Y44 Agents primarily affecting blood constituents
0.731 0.269 0.000
V80-V89 Other land transport accidents
0.731 0.269 0.000
A41 Other septicaemia
0.731 0.269 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.730 0.270 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.728 0.272 0.000
Y52.1 Calcium-channel blockers
0.728 0.272 0.000
N00-N08 Glomerular diseases
0.728 0.272 0.000
G30-G32 Other degenerative diseases of the nervous system
0.728 0.272 0.000
J06 Acute upper respiratory infections of multiple and unspecified sites
0.724 0.276 0.000
O85-O92 Complications predominantly related to the puerperium
0.724 0.276 0.000
J20 Acute bronchitis
0.722 0.278 0.000
N30 Cystitis
0.722 0.278 0.000
Q63 Other congenital malformations of kidney
0.722 0.278 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.721 0.279 0.000
N18.5 Chronic kidney disease, stage 5
0.719 0.281 0.000
Q50-Q56 Congenital malformations of genital organs
0.719 0.281 0.000
I22.9 Subsequent myocardial infarction of unspecified site
0.719 0.281 0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified
0.719 0.281 0.000
I08 Multiple valve diseases
0.718 0.282 0.000
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.718 0.282 0.000
G96 Other disorders of central nervous system
0.717 0.283 0.000
I52 Other heart disorders in diseases classified elsewhere
0.717 0.283 0.000
I48 Atrial fibrillation and flutter
0.717 0.283 0.000
I43 Cardiomyopathy in diseases classified elsewhere
0.717 0.283 0.000
I41 Myocarditis in diseases classified elsewhere
0.717 0.283 0.000
I40 Acute myocarditis
0.717 0.283 0.000
I39 Endocarditis and heart valve disorders in diseases classified elsewhere
0.717 0.283 0.000
I37 Pulmonary valve disorders
0.717 0.283 0.000
I36 Nonrheumatic tricuspid valve disorders
0.717 0.283 0.000
I32 Pericarditis in diseases classified elsewhere
0.717 0.283 0.000
I00-I02 Acute rheumatic fever
0.717 0.283 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
F99-F99 Unspecified mental disorder
0.716 0.284 0.000
I70-I79 Diseases of arteries, arterioles and capillaries
0.716 0.284 0.000
I38 Endocarditis, valve unspecified
0.716 0.284 0.000
Y45.2 Propionic acid derivatives
0.716 0.284 0.000
M45-M49 Spondylopathies
0.715 0.285 0.000
I50.9 Heart failure, unspecified
0.715 0.285 0.000
I51.5 Myocardial degeneration
0.715 0.285 0.000
I51.3 Intracardiac thrombosis, not elsewhere classified
0.715 0.285 0.000
I51.2 Rupture of papillary muscle, not elsewhere classified
0.715 0.285 0.000
I51.1 Rupture of chordae tendineae, not elsewhere classified
0.715 0.285 0.000
I15 Secondary hypertension
0.714 0.285 0.000
I13 Hypertensive heart and renal disease
0.714 0.285 0.000
F03 Unspecified dementia
0.714 0.286 0.000
Y57 Other and unspecified drugs and medicaments
0.714 0.286 0.000
A00-A09 Intestinal infectious diseases
0.711 0.289 0.000
Z30-Z39 Persons encountering health services in circumstances related to reproduction
0.711 0.289 0.000
H55-H59 Other disorders of eye and adnexa
0.710 0.290 0.000
V40-V49 Car occupant injured in transport accident
0.706 0.294 0.000
I49 Other cardiac arrhythmias
0.706 0.294 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.705 0.295 0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified
0.704 0.296 0.000
J12 Viral pneumonia, not elsewhere classified
0.704 0.296 0.000
J11 Influenza, virus not identified
0.704 0.296 0.000
J10 Influenza due to identified influenza virus
0.704 0.296 0.000
J09 Influenza due to certain identified influenza virus
0.704 0.296 0.000
I07.1 Tricuspid insufficiency
0.703 0.297 0.000
N51 Disorders of male genital organs in diseases classified elsewhere
0.703 0.297 0.000
N46 Male infertility
0.703 0.297 0.000
N44 Torsion of testis
0.703 0.297 0.000
J39.2 Other diseases of pharynx
0.702 0.298 0.000
B02 Zoster [herpes zoster]
0.702 0.298 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.700 0.300 0.000
J31.0 Chronic rhinitis
0.699 0.301 0.000
I05 Rheumatic mitral valve diseases
0.699 0.301 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.699 0.301 0.000
M80-M85 Disorders of bone density and structure
0.699 0.301 0.000
Y45.1 Salicylates
0.698 0.302 0.000
N42.3 Dysplasia of prostate
0.698 0.302 0.000
Y40 Systemic antibiotics
0.697 0.302 0.000
O43 Placental disorders
0.697 0.302 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.697 0.303 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.696 0.304 0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours
0.695 0.305 0.000
N18.4 Chronic kidney disease, stage 4
0.695 0.305 0.000
G24 Dystonia
0.695 0.305 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.694 0.306 0.000
Y35-Y36 Legal intervention and operations of war
0.694 0.306 0.000
Y10-Y34 Event of undetermined intent
0.694 0.306 0.000
Y00-Y09 Assault
0.694 0.306 0.000
X85-X99 Assault
0.694 0.306 0.000
X50-X57 Overexertion, travel and privation
0.694 0.306 0.000
X30-X39 Exposure to forces of nature
0.694 0.306 0.000
X10-X19 Contact with heat and hot substances
0.694 0.306 0.000
X00-X09 Exposure to smoke, fire and flames
0.694 0.306 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.694 0.306 0.000
W75-W84 Other accidental threats to breathing
0.694 0.306 0.000
W65-W74 Accidental drowning and submersion
0.694 0.306 0.000
W50-W64 Exposure to animate mechanical forces
0.694 0.306 0.000
V98-V99 Other and unspecified transport accidents
0.694 0.306 0.000
V95-V97 Air and space transport accidents
0.694 0.306 0.000
V90-V94 Water transport accidents
0.694 0.306 0.000
V70-V79 Bus occupant injured in transport accident
0.694 0.306 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.694 0.306 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.694 0.306 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.694 0.306 0.000
V01-V09 Pedestrian injured in transport accident
0.694 0.306 0.000
I61 Intracerebral haemorrhage
0.693 0.307 0.000
G25 Other extrapyramidal and movement disorders
0.692 0.308 0.000
X20-X29 Contact with venomous animals and plants
0.692 0.308 0.000
O41 Other disorders of amniotic fluid and membranes
0.691 0.309 0.000
H53 Visual disturbances
0.690 0.310 0.000
G90 Disorders of autonomic nervous system
0.690 0.310 0.000
N43.4 Spermatocele
0.690 0.310 0.000
N43.2 Other hydrocele
0.690 0.310 0.000
N43.1 Infected hydrocele
0.690 0.310 0.000
N43.0 Encysted hydrocele
0.690 0.310 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.689 0.311 0.000
J37 Chronic laryngitis and laryngotracheitis
0.689 0.311 0.000
N29 Other disorders of kidney and ureter in diseases classified elsewhere
0.687 0.312 0.000
N27 Small kidney of unknown cause
0.687 0.312 0.000
N25 Disorders resulting from impaired renal tubular function
0.687 0.312 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.687 0.313 0.000
O20-O29 Other maternal disorders predominantly related to pregnancy
0.687 0.313 0.000
A80-A89 Viral infections of the central nervous system
0.687 0.313 0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.686 0.314 0.000
Q35-Q37 Cleft lip and cleft palate
0.686 0.314 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.686 0.314 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.686 0.314 0.000
Z70-Z76 Persons encountering health services in other circumstances
0.685 0.315 0.000
J18.8 Other pneumonia, organism unspecified
0.684 0.316 0.000
J18.2 Hypostatic pneumonia, unspecified
0.684 0.316 0.000
N18.3 Chronic kidney disease, stage 3
0.684 0.316 0.000
X60-X84 Intentional self-harm
0.683 0.316 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.683 0.316 0.000
F70-F79 Mental retardation
0.683 0.316 0.000
Y59 Other and unspecified vaccines and biological substances
0.683 0.317 0.000
Y58 Bacterial vaccines
0.683 0.317 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.683 0.317 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.683 0.317 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.683 0.317 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.683 0.317 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.683 0.317 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.683 0.317 0.000
Y48 Anaesthetics and therapeutic gases
0.683 0.317 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.683 0.317 0.000
I68 Cerebrovascular disorders in diseases classified elsewhere
0.682 0.318 0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
0.682 0.318 0.000
N30.9 Cystitis, unspecified
0.681 0.319 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.680 0.320 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.678 0.321 0.000
W44.0 Home
0.677 0.323 0.000
B15-B19 Viral hepatitis
0.677 0.323 0.000
Y95 Nosocomial condition
0.676 0.324 0.000
B99-B99 Other infectious diseases
0.675 0.325 0.000
B85-B89 Pediculosis, acariasis and other infestations
0.675 0.325 0.000
B65-B83 Helminthiases
0.675 0.325 0.000
B50-B64 Protozoal diseases
0.675 0.325 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.675 0.325 0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
0.675 0.325 0.000
A75-A79 Rickettsioses
0.675 0.325 0.000
A70-A74 Other diseases caused by chlamydiae
0.675 0.325 0.000
A65-A69 Other spirochaetal diseases
0.675 0.325 0.000
A20-A28 Certain zoonotic bacterial diseases
0.675 0.325 0.000
A15-A19 Tuberculosis
0.675 0.325 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.672 0.328 0.000
J60-J70 Lung diseases due to external agents
0.671 0.329 0.000
J15.4 Pneumonia due to other streptococci
0.671 0.329 0.000
G82 Paraplegia and tetraplegia
0.671 0.329 0.000
I31.8 Other specified diseases of pericardium
0.671 0.329 0.000
I31.2 Haemopericardium, not elsewhere classified
0.671 0.329 0.000
I31.1 Chronic constrictive pericarditis
0.671 0.329 0.000
I31.0 Chronic adhesive pericarditis
0.671 0.329 0.000
Z30 Contraceptive management
0.670 0.330 0.000
F17 Mental and behavioural disorders due to use of tobacco
0.670 0.330 0.000
A46 Erysipelas
0.670 0.330 0.000
V20-V29 Motorcycle rider injured in transport accident
0.669 0.331 0.000
F45 Somatoform disorders
0.667 0.333 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.666 0.334 0.000
J32.8 Other chronic sinusitis
0.665 0.335 0.000
I35 Nonrheumatic aortic valve disorders
0.665 0.335 0.000
F80-F89 Disorders of psychological development
0.664 0.336 0.000
M47 Spondylosis
0.664 0.336 0.000
N41.0 Acute prostatitis
0.663 0.337 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.663 0.337 0.000
W00-W19 Falls
0.662 0.338 0.000
Y45.0 Opioids and related analgesics
0.662 0.338 0.000
G23 Other degenerative diseases of basal ganglia
0.661 0.339 0.000
G21 Secondary Parkinsonism
0.661 0.339 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.661 0.339 0.000
G22 Parkinsonism in diseases classified elsewhere
0.661 0.339 0.000
J32.4 Chronic pansinusitis
0.661 0.339 0.000
J32.3 Chronic sphenoidal sinusitis
0.661 0.339 0.000
J32.1 Chronic frontal sinusitis
0.661 0.339 0.000
J39.8 Other specified diseases of upper respiratory tract
0.661 0.339 0.000
Z36 Antenatal screening
0.661 0.339 0.000
J13 Pneumonia due to Streptococcus pneumoniae
0.660 0.340 0.000
N99-N99 Other disorders of the genitourinary system
0.659 0.340 0.000
I25.3 Aneurysm of heart
0.659 0.341 0.000
A40 Streptococcal septicaemia
0.659 0.341 0.000
O34.1 Maternal care for tumour of corpus uteri
0.657 0.343 0.000
F48 Other neurotic disorders
0.657 0.343 0.000
F44 Dissociative [conversion] disorders
0.657 0.343 0.000
F42 Obsessive-compulsive disorder
0.657 0.343 0.000
N42.2 Atrophy of prostate
0.657 0.343 0.000
J06.9 Acute upper respiratory infection, unspecified
0.657 0.343 0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.657 0.343 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.656 0.344 0.000
J32.0 Chronic maxillary sinusitis
0.656 0.344 0.000
I23 Certain current complications following acute myocardial infarction
0.655 0.345 0.000
J21.9 Acute bronchiolitis, unspecified
0.653 0.347 0.000
O40 Polyhydramnios
0.653 0.347 0.000
A50-A64 Infections with a predominantly sexual mode of transmission
0.652 0.348 0.000
F60-F69 Disorders of adult personality and behaviour
0.651 0.349 0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves
0.651 0.349 0.000
W49 Exposure to other and unspecified inanimate mechanical forces
0.651 0.349 0.000
N30.1 Interstitial cystitis (chronic)
0.649 0.351 0.000
I09 Other rheumatic heart diseases
0.648 0.351 0.000
I06 Rheumatic aortic valve diseases
0.648 0.351 0.000
N28.9 Disorder of kidney and ureter, unspecified
0.648 0.352 0.000
G70-G73 Diseases of myoneural junction and muscle
0.647 0.353 0.000
Q60 Renal agenesis and other reduction defects of kidney
0.646 0.354 0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified
0.645 0.355 0.000
J35.0 Chronic tonsillitis
0.644 0.356 0.000
G80.9 Infantile cerebral palsy, unspecified
0.644 0.356 0.000
G96.0 Cerebrospinal fluid leak
0.643 0.357 0.000
J98 Other respiratory disorders
0.642 0.358 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.642 0.358 0.000
Q64 Other congenital malformations of urinary system
0.641 0.359 0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
0.641 0.359 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.641 0.359 0.000
W22 Striking against or struck by other objects
0.641 0.359 0.000
I34.8 Other nonrheumatic mitral valve disorders
0.640 0.360 0.000
I34.2 Nonrheumatic mitral (valve) stenosis
0.640 0.360 0.000
O44 Placenta praevia
0.640 0.360 0.000
O45 Premature separation of placenta [abruptio placentae]
0.638 0.362 0.000
O35 Maternal care for known or suspected foetal abnormality and damage
0.638 0.362 0.000
O33 Maternal care for known or suspected disproportion
0.638 0.362 0.000
O31 Complications specific to multiple gestation
0.638 0.362 0.000
F17.1 Harmful use
0.637 0.363 0.000
I24.8 Other forms of acute ischaemic heart disease
0.637 0.363 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.637 0.363 0.000
Y45.8 Other analgesics and antipyretics
0.637 0.363 0.000
Y45.5 4-Aminophenol derivatives
0.637 0.363 0.000
Y45.4 Antirheumatics
0.637 0.363 0.000
O47.1 False labour at or after 37 completed weeks of gestation
0.637 0.363 0.000
F41.8 Other specified anxiety disorders
0.637 0.363 0.000
F41.3 Other mixed anxiety disorders
0.637 0.363 0.000
A08 Viral and other specified intestinal infections
0.635 0.365 0.000
Z36.8 Other antenatal screening
0.635 0.365 0.000
I34.1 Mitral (valve) prolapse
0.633 0.367 0.000
I62 Other nontraumatic intracranial haemorrhage
0.633 0.367 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.632 0.368 0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
0.631 0.369 0.000
Q07 Other congenital malformations of nervous system
0.631 0.369 0.000
B37 Candidiasis
0.631 0.369 0.000
N34 Urethritis and urethral syndrome
0.629 0.371 0.000
H10-H13 Disorders of conjunctiva
0.629 0.371 0.000
I63 Cerebral infarction
0.628 0.372 0.000
D55-D59 Haemolytic anaemias
0.628 0.372 0.000
Y43 Primarily systemic agents
0.628 0.372 0.000
O32 Maternal care for known or suspected malpresentation of foetus
0.628 0.372 0.000
B49 Unspecified mycosis
0.627 0.372 0.000
J31.2 Chronic pharyngitis
0.627 0.373 0.000
M80 Osteoporosis with pathological fracture
0.626 0.374 0.000
A41.9 Septicaemia, unspecified
0.626 0.374 0.000
N18.9 Chronic renal failure, unspecified
0.626 0.374 0.000
A48 Other bacterial diseases, not elsewhere classified
0.625 0.375 0.000
A44 Bartonellosis
0.625 0.375 0.000
A43 Nocardiosis
0.625 0.375 0.000
A42 Actinomycosis
0.625 0.375 0.000
A39 Meningococcal infection
0.625 0.375 0.000
A37 Whooping cough
0.625 0.375 0.000
A36 Diphtheria
0.625 0.375 0.000
A32 Listeriosis
0.625 0.375 0.000
A31 Infection due to other mycobacteria
0.625 0.375 0.000
A30 Leprosy [Hansen's disease]
0.625 0.375 0.000
A38 Scarlet fever
0.625 0.375 0.000
A35 Other tetanus
0.625 0.375 0.000
A34 Obstetrical tetanus
0.625 0.375 0.000
A33 Tetanus neonatorum
0.625 0.375 0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.625 0.375 0.000
I30.1 Infective pericarditis
0.624 0.376 0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device
0.624 0.376 0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.624 0.376 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.624 0.376 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.624 0.376 0.000
Y52.7 Peripheral vasodilators
0.624 0.376 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.624 0.376 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.624 0.376 0.000
J15.1 Pneumonia due to Pseudomonas
0.623 0.377 0.000
A49.0 Staphylococcal infection, unspecified
0.623 0.377 0.000
Y47.1 Benzodiazepines
0.621 0.379 0.000
J38.2 Nodules of vocal cords
0.621 0.379 0.000
J18.9 Pneumonia, unspecified
0.621 0.379 0.000
J80-J84 Other respiratory diseases principally affecting the interstitium
0.620 0.380 0.000
B91 Sequelae of poliomyelitis
0.620 0.380 0.000
I60.9 Subarachnoid haemorrhage, unspecified
0.620 0.380 0.000
N18.8 Other chronic renal failure
0.619 0.381 0.000
N18.1 Chronic kidney disease, stage 1
0.619 0.381 0.000
H53.2 Diplopia
0.618 0.382 0.000
J38.0 Paralysis of vocal cords and larynx
0.618 0.382 0.000
I95-I99 Other and unspecified disorders of the circulatory system
0.617 0.382 0.000
Z35 Supervision of high-risk pregnancy
0.617 0.383 0.000
B00 Herpesviral [herpes simplex] infections
0.616 0.384 0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
0.616 0.384 0.000
G83.4 Cauda equina syndrome
0.614 0.386 0.000
N41.1 Chronic prostatitis
0.612 0.388 0.000
M86-M90 Other osteopathies
0.611 0.389 0.000
W21 Striking against or struck by sports equipment
0.611 0.389 0.000
I11.9 Hypertensive heart disease without (congestive) heart failure
0.610 0.389 0.000
Z71.8 Other specified counselling
0.610 0.390 0.000
M05-M14 Inflammatory polyarthropathies
0.609 0.391 0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified
0.609 0.391 0.000
F40.2 Specific (isolated) phobias
0.609 0.391 0.000
H53.9 Visual disturbance, unspecified
0.609 0.391 0.000
H57 Other disorders of eye and adnexa
0.607 0.393 0.000
M85 Other disorders of bone density and structure
0.607 0.393 0.000
W46 Contact with hypodermic needle
0.606 0.394 0.000
W45 Foreign body or object entering through skin
0.606 0.394 0.000
W43 Exposure to vibration
0.606 0.394 0.000
W42 Exposure to noise
0.606 0.394 0.000
W41 Exposure to high-pressure jet
0.606 0.394 0.000
W40 Explosion of other materials
0.606 0.394 0.000
W39 Discharge of firework
0.606 0.394 0.000
W38 Explosion and rupture of other specified pressurised devices
0.606 0.394 0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose
0.606 0.394 0.000
W36 Explosion and rupture of gas cylinder
0.606 0.394 0.000
W35 Explosion and rupture of boiler
0.606 0.394 0.000
W34 Discharge from other and unspecified firearms
0.606 0.394 0.000
W33 Rifle, shotgun and larger firearm discharge
0.606 0.394 0.000
W32 Handgun discharge
0.606 0.394 0.000
W31 Contact with other and unspecified machinery
0.606 0.394 0.000
W30 Contact with agricultural machinery
0.606 0.394 0.000
W28 Contact with powered lawn mower
0.606 0.394 0.000
W27 Contact with nonpowered hand tool
0.606 0.394 0.000
W26 Contact with knife, sword or dagger
0.606 0.394 0.000
W24 Contact with lifting and transmission devices, not elsewhere classified
0.606 0.394 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.606 0.394 0.000
W20 Struck by thrown, projected or falling object
0.606 0.394 0.000
J33.9 Nasal polyp, unspecified
0.604 0.396 0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.604 0.396 0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries
0.604 0.396 0.000
I60.5 Subarachnoid haemorrhage from vertebral artery
0.604 0.396 0.000
I60.4 Subarachnoid haemorrhage from basilar artery
0.604 0.396 0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.604 0.396 0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.604 0.396 0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.604 0.396 0.000
A41.1 Septicaemia due to other specified staphylococcus
0.603 0.397 0.000
H18 Other disorders of cornea
0.602 0.398 0.000
J18.0 Bronchopneumonia, unspecified
0.601 0.398 0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation
0.601 0.399 0.000
J33.8 Other polyp of sinus
0.600 0.400 0.000
J98.1 Pulmonary collapse
0.600 0.400 0.000
A41.0 Septicaemia due to Staphylococcus aureus
0.600 0.400 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.599 0.400 0.000
I65.2 Occlusion and stenosis of carotid artery
0.599 0.401 0.000
Q63.0 Accessory kidney
0.598 0.402 0.000
I49.5 Sick sinus syndrome
0.598 0.402 0.000
O30 Multiple gestation
0.598 0.402 0.000
I25.6 Silent myocardial ischaemia
0.597 0.402 0.000
I25.4 Coronary artery aneurysm
0.597 0.402 0.000
I25.0 Atherosclerotic cardiovascular disease, so described
0.597 0.402 0.000
J17.0 Pneumonia in bacterial diseases classified elsewhere
0.597 0.403 0.000
J39.9 Disease of upper respiratory tract, unspecified
0.596 0.404 0.000
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified
0.596 0.404 0.000
J39.1 Other abscess of pharynx
0.596 0.404 0.000
J39.0 Retropharyngeal and parapharyngeal abscess
0.596 0.404 0.000
M65-M68 Disorders of synovium and tendon
0.596 0.404 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.